The Redox Podcast

The Redox Podcast

Explore some of the biggest problems in healthcare, and hear from industry leaders about how technology is being deployed to solve them.

Latest From Series

#36 Therapy for Kids with Manatee's Dama Dipayana

On today’s show, we have Damayanti Dipayana, the co-founder and CEO of Manatee Health, based in the Mile High city of health tech, Denver, Colorado. We get into the Manatee story and the big splash they made as they launched winning the HLTH pitch competition, Prime Health, and graduating from Techstars. We also get into how Dama manages running an early stage startup with three kids under 4. Truly a herculean feat that she shrugs off as a days work.
January 20, 2021

#35 A Christmas Carol in Quarantine

As we live through the holidays in quarantine, Niko gets visited by the ghosts of health crises past, present, and future. How did we get here? What can we learn from prior pandemics and vaccine distribution? Are we entering the era of pandemics? Our ghosts, played and written by Rachel Desmond, share these and many more insights, giving us a broad view for our current state of affairs.
December 22, 2020

#34 Our Social Dilemma: Mental Health in the time of Big Tech with Dr. David Elkin of UMMC

Today on the show we have Dr. David Elkin. He is a pediatric clinical psychologist and founder and executive director of the Center for Advancement of Youth at University of Mississippi Medical Center. The center is a multi-disciplinary approach to coordinated for children with behavioral or developmental issues throughout Mississippi. I’ve got to say that I really really enjoyed this conversation. We explored how social media/big tech and the pandemic are feeding into mental health issues in our youth as well as the technology being used and contemplated at UMMC to deliver more streamlined mental healthcare. 
December 15, 2020

#33 Regulated consumer health apps with Natural Cycles’ CEO (and particle physicist) Elina Berglund, PhD

What does the God particle have in common with the only FDA-cleared birth control app? The answer: Natural Cycles. CEO, Dr. Elina Berglund was once a part of the team that found evidence of the media-paraded God Particle, otherwise known as the Higgs Boson. Post this literal Earth-shaking discovery, Dr. Berglund and her team spent the better part of the past decade perfecting an algorithm for a contraceptive app that is 98% effective with perfect use. Beyond impressive. That app is called Natural Cycles. It is the only birth-control app ever to be cleared by the FDA. In this episode we discuss Dr Berglund’s unique journey into the tech world, the difference between tech people and physicists, and what exactly makes the Higgs Boson such a game changer. Gotta say, it’s the simplest explanation I’ve heard on the topic.
December 8, 2020

#32 Payal from .406 Ventures on Investing in Healthcare Technology

On today’s show we have Payal Agrawal Divakaran. She leads digital health investments as a partner at .406 Ventures in Boston who was, of course, the first institutional investor to bet on Redox, leading our Series A back in October of 2015. We discuss some of her journey as well as where she’s making (and has made) bets in healthcare technology. This includes Redox, AristaMD, Heartbeat Health, WellbeHealth, and Axial. We also discuss areas where she has an active thesis and is looking for investments. 
November 24, 2020

#31 The Lasting Impact of COVID19 on Healthcare Technology with Terrence Hibbert

We started doing this show back in November 2019, back before the world changed. Then, in March, we got the pandemic that really made everything we were talking about up until that point moot. On today’s show, we’re going to dive into some of those changes. I invited our early guests on the podcast to make a quick video answering the question: What will be the lasting impact of the pandemic on healthcare technology? We’ll hear from Dr. Bill Hansen, CMIO of UPenn, Jonathan Bush, Executive Chairman of Firefly and founder of athenahealth, Stephanie Tilenius CEO of Vida, Aaron Patzer CEO of Vital, and many more. There are certainly themes that carry throughout, but there are also different messages that are worth discussing and delving deeper into. So, to help with that delving, I’ve invited an old friend of mine, Terrence Hibbert to hang out with me and talk through some of these predictions. Terrence was most recently the Director of Innovation at University of Mississippi Medical Center. Prior to that, he was the director of IT Solution strategy at UMC. This show was developed as part of a Redox's Quarterly event and is also available via video. Check it out here:
November 18, 2020

Listen on your favorite player

New to Podcasts? It's easy to get started!

The Redox Podcast

Redox exists to improve healthcare by uniting patients and providers through easily accessible technology. Technology can dramatically improve healthcare. It helps healthcare organizations become more efficient. It gives patients more control of their healthcare experience. And when done right, technology removes distractions so providers can focus on what’s important: their patients.
View All Episodes


Niko Skievaski

Niko Skievaski

Niko is the President & Co-Founder of Redox, a leading interoperability platform powering digital health innovation at more than 700 healthcare organizations. Prior, he worked at Epic, where he saw first hand how the need to solve interoperability is one of the biggest challenges facing healthcare today. He's the Co-founder of 100state, Wisconsin's largest co-working space, and creator of Struck by Orca, healthcare's pivotal book on ICD-10. He has degrees in Economics from Arizona State and Boston University and lives in Boulder, CO with his partner, toddler, and collection of mountain bikes.

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

Hera Diagnostics is eradicating cervical cancer in developing communities Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market.